MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Basal ganglia"

  • 2025 International Congress

    Relationship Between Cortico-basal ganglia Beta Oscillations and Excessive Daytime Sleepiness in Parkinsonism

    A. Verma, K. Acedillo, B. Nandakumar, N. Hjelle, H. Baker, D. Schneck, B. Mohanty, M. Fiecas, J. Wang, M. Howell, C. Mackinnon, J. Vitek, L. Johnson (Minneapolis, USA)

    Objective: To examine the relationship between beta oscillations in the cortico-basal ganglia circuit and daytime vigilance in parkinsonism. Background: Exaggerated beta oscillations in the cortico-basal…
  • 2025 International Congress

    The importance of vascular anomalies and endothelin-1 factor in the development of vascular parkinsonism

    R. Juraev, R. Matmurodov, S. Jumanazarova (Tashkent, Uzbekistan)

    Objective: To study the relationship between vascular endothelium and vascular anomalies in the development of vascular parkinsonism. Background: Although vascular parkinsonism (VP) is relatively rare,…
  • 2025 International Congress

    A case of bilateral asterixis following hemichorea-hemiballism due to bilateral internal carotid artery stenosis

    S. Mamada, R. Yokoyama, K. Seo, H. Kawasaki, Y. Ito, G. Oyama, T. Yamamoto (Saitama, Japan)

    Objective: To report a rare case of bilateral asterixis occurring one year after the onset of hemichorea-hemiballism in a patient with severe bilateral internal carotid…
  • 2025 International Congress

    Vision in Motion: Eye Exercises to Enhance Balance in Parkinson’s Disease – A Randomized Controlled Trial

    MA. Tabibi, A. Chitsaz, F. Nazemi, N. Salimian (Isfahan, Islamic Republic of Iran)

    Objective: 1. Primary Objective:  Confirm the effectiveness of innovative eye exercises in improving balance over a 12-week intervention period.2. Secondary Objectives:    Evaluate reductions in…
  • 2025 International Congress

    White Matter and Subcortical Alterations in Focal Dystonia: A MRI Study of Subtype-Specific Brain Changes

    J. de Paiva, D. de Faria, V. Borges, S. Silva, H. de Ferraz, P. Aguiar (Sao Paulo, Brazil)

    Objective: To assess structural brain alterations in patients with cervical dystonia (CD) and focal upper limb dystonia (ULD) relative to healthy controls, using MRI exploratory…
  • 2025 International Congress

    Preservation of Putamen Volume with Aging in Cervical Dystonia, not other focal dystonia subtypes: A Cross-Sectional Neuroimaging Study

    M. Owusu-Ansah, A. Tanenbaum, J. Hood, A. Eid, S. Grossen, A. Morris, PT. Kotzbauer, J. Perlmutter, MC. Campbell, SA. Norris (Saint Louis, USA)

    Objective: To investigate whether focal dystonia is associated with altered structural age-related changes in the putamen compared to healthy controls and across dystonia subtypes. Background:…
  • 2025 International Congress

    Investigation of cortex – basal ganglia pathways with cortical stimulation and subthalamic evoked responses in patients with Parkinson’s disease

    J-C. Beyer, A. Cavallo, R M. Köhler, J. Vanhoecke, G-H. Schneider, A A. Kühn, W-J. Neumann (Berlin, Germany)

    Objective: To investigate the electrophysiological interplay between the human cortex and the subthalamic nucleus (STN) by comparing STN responses to direct cortical electrical stimulation and…
  • 2025 International Congress

    LRRK2 antisense oligonucleotide (BIIB094/ION859) impact on cerebrospinal fluid biomarkers in Parkinson’s disease patients

    O. Mabrouk (cambridge, USA)

    Objective: To provide novel fluid biomarker results from REASON – a Phase 1 clinical trial testing a LRRK2 antisense oligonucleotide in both LRRK2-Parkinson’s disease and…
  • 2025 International Congress

    Differential Motor Cortex Compensation in Parkinson’s Disease based on Putamen Neurodegeneration Laterality: Insights from EEG and [¹⁸F]FDOPA PET/CT

    K. Lorek, J. Mączewska, L. Królicki, K. Markowska, M. Koszewicz, S. Budrewicz, M. Chalimoniuk, J. Marusiak (Wroclaw, Poland)

    Objective: To investigate differences in motor cortex compensation across Parkinson’s disease (PD) patients with different putamen neurodegeneration laterality. Background: Abnormalities in the putamen–motor cortex (M1)…
  • 2024 International Congress

    the role of metabotropic glutamate receptors type 3 and 5 in parkinson’s disease: analysis of grm3 and grm5 genbe variants.

    M. Alborghetti, E. Bianchini, D. Rinaldi, I. de Bartolo, L. Di Menna, G. Battaglia, V. Bruno, T. Esposito, M. Borro, M. Simmaco, F. Pontieri, A. Berardelli, F. Nicoletti (Rome, Italy)

    Objective: The aim of the study was to examine the association between polymorphic variants of GRM3 and GRM5 and Parkinson’s disease (PD) and motor and…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 23
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley